where to buy adagrasib

Adagrasib (Adagrasib) is a small molecule inhibitor that targets the KRAS G12C mutation. KRAS gene mutations are common in a variety of cancers, such as non-small cell lung cancer, colorectal cancer, and pancreatic cancer. Traditional KRAS mutation-targeted treatments are very limited. Adagrasiib blocks the growth and proliferation of tumor cells by binding to the KRAS G12C mutant protein and inhibiting its activity. Clinical studies have shown that adagrasib has shown certain therapeutic effects in patients with non-small cell lung cancer and other solid tumors carrying KRAS G12C mutations.

It should be noted that the use of adagrasib needs to be under the guidance of a doctor, and its efficacy and safety may vary depending on individual differences and tumor characteristics. In addition, cancer treatment is often a comprehensive process that may include other treatments such as chemotherapy, radiation therapy, and immunotherapy. Have regular checkups and monitoring as recommended by your doctor to evaluate the effectiveness of treatment and monitor for possible side effects. This may include regular blood tests, imaging tests, etc. Adagrasiib may cause some side effects, such as diarrhea, nausea, fatigue, etc. If side effects occur, inform your doctor promptly, and your doctor may adjust the dose or provide corresponding treatment measures.

Since the original drug of adagrasib has not yet been launched in China, patients can only purchase adagrasib through overseas channels. The specifications of the original version of adagrasib in the United States The price of each box of 200mg*180 tablets is more than 100,000 yuan (the price may fluctuate due to the exchange rate), which is very expensive. Currently, there are no generic adagrasibu produced in other countries overseas. For more drug information and specific prices, please consult Yaode Medical Consultant.